Загрузка...

Successful response to first-line treatment with osimertinib for choroidal metastasis from EGFR-mutated non-small-cell lung cancer

Purpose: Describe the use of osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, as the first-line treatment in a patient with choroidal and central nervous system metastases from EGFR-mutated non-small cell lung cancer. Observations: A 68-year-old man...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Matthew G. Field, H. Culver Boldt, Taher Abu Hejleh, Elaine M. Binkley
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier 2022-06-01
Серии:American Journal of Ophthalmology Case Reports
Предметы:
Online-ссылка:http://www.sciencedirect.com/science/article/pii/S2451993622002055
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!